ICIS - Search Articles by Date : April 25 2005 - May 01 2005

Chemical Commodities Monthly
Our monthly wrap-ip of the commodity chemical markets more
(29 April 2005 20:38)

Shugr enters US sweeteners market
Another low/zero-calorie sweetener will soon add its weight to the highly competitive sugar alternatives market. Health Sciences Group Inc., through.... more
(29 April 2005 20:38)

Degussa takes over Cyro joint venture
Degussa AG has signed an agreement to acquire Cytec Industries Inc.’s 50 percent stake in their Cyro Industries joint venture for $95 million. Once.... more
(29 April 2005 20:38)

Dow and Lyondell pound Wall Street
Commodity chemical companies are blasting through Wall Street estimates in the first quarter as robust pricing and strong volumes trumped higher raw.... more
(29 April 2005 20:38)

DuPont 1Q falls short
DuPont fell short of Wall Street expectations in the first quarter but affirmed its guidance for a strong 2005. The company posted earnings per share.... more
(29 April 2005 20:38)

BASF increases Ecoflex capacity
BASF will start up a new plant for Ecoflex, a biodegradable styrenic plastic, at its Schwarzheide site in Germany in early 2006. The new plant will.... more
(29 April 2005 20:38)

Engineering & construction in brief
Aker Kvaerner has been awarded a contract by DSM Engineering Plastics BV for the first phase of engineering for the expansion of its diaminobutane.... more
(29 April 2005 20:38)

Technip lands Qatar cracker project
Paris-based contractor Technip has inked a letter of intent with Qatar Petroleum, Chevron Phillips Chemical Company LLC (CPChem), Qatar Petrochemical.... more
(29 April 2005 20:38)

Foster Wheeler in China CTL study
Foster Wheeler Energy Ltd., in a joint venture with China Huanqui Contracting and Engineering Corp., has been awarded a feasibility study Stage I.... more
(29 April 2005 20:38)

ExxonMobil mulls Singapore train
ExxonMobil Chemical says a feasibility study for a second steam-cracking train in Singa-pore is progressing, although it is still in the early.... more
(29 April 2005 20:38)

Hexion to go public in $800 million IPO
Apollo to create $4 billion specialty chemicals leader. Joseph Chang reports more
(29 April 2005 20:38)

Specialties post mixed first quarter
Specialty chemical firms are posting mixed results in the first quarter as some were able to exercise pricing power better than others. more
(29 April 2005 20:38)

GSK, FDA in accord on quality
GlaxoSmithKline is poised to relaunch two drugs after reaching a deal with the Food and Drug Administration (FDA) to resolve manufacturing issues at.... more
(29 April 2005 20:38)

Industrial gas giants post profits
The industrial gas giants had a banner March quarter, putting up robust sales and profit numbers. The outlook for the rest of the year is positive on.... more
(29 April 2005 20:38)

Apollo to create Hexion
In a bid to create the third-largest specialty chemical company in North America with sales of over $4 billion and the global leader in thermosetting.... more
(29 April 2005 20:38)

Huntsman expands maleic anhydride
Huntsman Corp. will ex-pand its maleic anhydride production capacity by about 40 percent, adding 100 million pounds to bring its US capacity to 335.... more
(29 April 2005 20:38)

Arch’s hydrazine poised for take-off
Arch Chemicals Inc.’s hydrazine business has been on a rollercoaster ride over the last year. In May 2004, the Norwalk, Conn.-based firm lost its.... more
(29 April 2005 20:38)

Industrial specialties in brief
Dow Corning’s new sealant technology more
(29 April 2005 20:38)

Chloralkali market maintains record pace
The US chloralkali market continues its record run, with another successful round of price increases as well as a healthy outlook for at least the.... more
(29 April 2005 20:38)

Life sciences in brief
Amgen and Abgenix Inc. have initiated a Phase III clinical trial to evaluate their experimental monoclonal antibody, panitumumab, in combination with.... more
(29 April 2005 20:38)

Amgen bests Street estimates in 1Q
Despite rather disappointing sales in its erythropoeitin franchise, Amgen Inc. posted strong earnings-per-share growth in the first quarter,.... more
(29 April 2005 20:38)

BASF posts strong 1Q
BASF increased sales by 11 percent in the first quarter to €10.1 billion ($13.1 billion) with underlying operating profit (EBIT) rising 33 percent to.... more
(29 April 2005 20:38)

Europe in brief
SERONO has set aside $725 million in a one-time charge in connection with a US investigation into price setting of its AIDS drug Serostim. The.... more
(29 April 2005 20:38)

Ciba expects margin improvement
Ciba Specialty Chemicals expects to recoup the increases in raw material costs over the past year by gaining average price increases of 3 percent.... more
(29 April 2005 20:38)

Novartis ups malaria drug production
Novartis is quadrupling production of a low-cost anti-malarial drug with the help of backward integration to the cultivation of the crop providing.... more
(29 April 2005 20:38)

In Eastern Europe, contract manufacturing remains largely untapped, opportunistic activity
Few Eastern European producers of pharmaceutical intermediates or active ingredients emphasize contract manufacturing. Instead, they serve mainly.... more
(29 April 2005 20:38)

News watch in brief
Sabic selects Hostalen more
(29 April 2005 20:38)

News watch in brief
Huntsman to expand ethanolamines more
(29 April 2005 20:38)

Sasol, Total abort wax jv plans in Europe
The planned wax joint venture between Sasol Wax International AG, a wholly owned subsidiary of Sasol Group, and Total France SA., a division of Total.... more
(29 April 2005 20:38)